Ameriprise
STAB

Ameriprise’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Ameriprise’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50
Closed – – 4565
2014
Q3 		$0 Hold
50
– – ﹤0.01% 5925
2014
Q2 		$0 Buy
50
+47
+1,567% +$549 ﹤0.01% 5681
2014
Q1 		$0 Hold
3
– – ﹤0.01% 5422
2013
Q4 		$0 Hold
3
– – ﹤0.01% 5476
2013
Q3 		$0 Hold
3
– – ﹤0.01% 5694
2013
Q2 		$0 Buy
+3
New +$103 ﹤0.01% 5589

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Ameriprise's STAB Position: Q4 2014 in Review

Ameriprise sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2014, closing a stake of 50 shares.

Ameriprise first reported a position in STAB in Q2 2013 and held it in 6 quarters. The position peaked at $0 in Q3 2014. 24 funds tracked by Wall St. Rank hold STAB as of Q4 2014.

  • Ameriprise reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 50 Statera Biopharma, Inc. Common Stock shares in Q4 2014.
  • Ameriprise first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q3 2014.
  • 24 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.